药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Cysteamine
Isosorbide mononitrate
The risk or severity of adverse effects can be increased when Isosorbide mononitrate is combined with Clomipramine.
Cysteamine
Cilnidipine
The risk or severity of adverse effects can be increased when Clomipramine is combined with Cilnidipine.
Cysteamine
Isosorbide dinitrate
The risk or severity of adverse effects can be increased when Isosorbide dinitrate is combined with Clomipramine.
Cysteamine
Fimasartan
The risk or severity of adverse effects can be increased when Clomipramine is combined with Fimasartan.
Cysteamine
Nitrous acid
The risk or severity of adverse effects can be increased when Clomipramine is combined with Nitrous acid.
Cysteamine
Dinutuximab
The risk or severity of adverse effects can be increased when Clomipramine is combined with Dinutuximab.
Cysteamine
Obinutuzumab
The risk or severity of adverse effects can be increased when Clomipramine is combined with Obinutuzumab.
Cysteamine
Azilsartan medoxomil
The risk or severity of adverse effects can be increased when Clomipramine is combined with Azilsartan medoxomil.
Cysteamine
Nesiritide
The risk or severity of adverse effects can be increased when Clomipramine is combined with Nesiritide.
Cysteamine
Amyl Nitrite
The risk or severity of adverse effects can be increased when Clomipramine is combined with Amyl Nitrite.
Cysteamine
Carbetocin
The risk or severity of adverse effects can be increased when Clomipramine is combined with Carbetocin.
Cysteamine
Amifostine
The risk or severity of adverse effects can be increased when Amifostine is combined with Clomipramine.
Cysteamine
Relugolix
The risk or severity of QTc prolongation can be increased when Relugolix is combined with Clomipramine.
Cysteamine
Fostemsavir
The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Clomipramine.
Cysteamine
Inotersen
The risk or severity of QTc prolongation can be increased when Inotersen is combined with Clomipramine.
Cysteamine
Delafloxacin
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Clomipramine.
Cysteamine
Acrivastine
The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Clomipramine.
Cysteamine
Acetyldigoxin
The risk or severity of QTc prolongation can be increased when Acetyldigoxin is combined with Clomipramine.
Cysteamine
Digitoxin
The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Clomipramine.
Cysteamine
Indacaterol
The risk or severity of QTc prolongation can be increased when Clomipramine is combined with Indacaterol.